Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00099567 · ClinicalTrials.gov registry record
Metabolic Syndrome, Inflammation, and Risk of Cognitive Decline
A clinical trial, sponsored by National Institute on Aging (NIA).
- Completed
- Registry status
- 2,632
- Enrollment target
NCT00099567: Completed study, sponsored by National Institute on Aging (NIA).
NCT00099567 is a clinical trial that has completed, run by National Institute on Aging (NIA). The registered enrollment target is 2,632 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00099567 has completed, sponsored by National Institute on Aging (NIA).
- COMPLETED
- Registry status
- 2,632 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if the metabolic syndrome is a risk factor for cognitive decline and if this association is modified by inflammation.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,632 participants |
| Start Date | 1997-01 |
| Est. Completion | 2002-12 |
What the finished NCT00099567 record still lists
NCT00099567 is an observational study that tracks outcomes without assigning an intervention. Its 2,632 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT00099567 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00099567 about?
NCT00099567 is a clinical study titled "Metabolic Syndrome, Inflammation, and Risk of Cognitive Decline". The purpose of this study is to determine if the metabolic syndrome is a risk factor for cognitive decline and if this association is modified by inflammation.
What is the current status of trial NCT00099567?
This trial is currently completed. The enrollment target is 2,632 participants. The study started on 1997-01. Estimated completion is 2002-12.
Who is sponsoring clinical trial NCT00099567?
This trial is sponsored by National Institute on Aging (NIA), which has 131 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06455085 · 2,634 participants · NA
RESTORE: REducing Future fractureS and Improving ouTcOmes of fRagility fracturE
- NCT06825715 · 2,653 participants · NA
Multilevel Intervention for Precision Oncology
- NCT06033950 · 2,600 participants · Phase 3
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure Who Are Intolerant or Not Eligible for Treatment with Steroidal Mineralocorticoid Receptor Antagonists
- NCT06574672 · 2,600 participants · NA
Embedded Palliative Care in the MICU
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia